Genticel, a clinical biopharmaceutical company developing vaccines for human papillomavirus (HPV), has appointed Dr. Didier Hoch to the company’s supervisory board.

Dr. Hoch brings more than 25 years of experience in the pharmaceutical industry to Genticel. His career in the vaccine industry includes 10 years as president of Sanofi-Pasteur-MSD, which launched Gardasil, a preventive HPV vaccine.